Akebia Therapeutics (AKBA) Tax Rate (2018 - 2026)
Akebia Therapeutics (AKBA) reported Tax Rate of 1.41% for Q1 2026, up 84.29% quarter-over-quarter from 8.98% in Q4 2025.
Akebia Therapeutics (AKBA) Tax Rate (2018 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has 4 years of Tax Rate data on file, last reported at 1.41% in Q1 2026.
- Tax Rate for Q1 2026 came in at 1.41%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 9.33% (changed N/A YoY), and the FY2025 annual result was 43.64%, changed N/A from the prior year.
- Tax Rate rose to 1.41% in Q1 2026 per AKBA's latest filing, from 8.98% in the prior quarter.
- Over five years, Tax Rate peaked at 53.25% in Q3 2025 and troughed at 8.98% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 15.33% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.71% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 13.63% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -20.44% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 19.81% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 34.48% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -7.43% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 9.29% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 24.29% |
| 10 | Akebia Therapeutics | 243.23 Mn | 80.63 Mn | 41.25 Mn | -1.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.41% |
| Mar 31, 2026 | -1.41% |
| Dec 31, 2025 | -8.98% |
| Dec 31, 2025 | -8.98% |
| Sep 30, 2025 | 53.25% |
| Sep 30, 2025 | 53.25% |
| Dec 31, 2019 | 6.86% |
| Dec 31, 2019 | 6.86% |
| Sep 30, 2019 | 2.29% |
| Sep 30, 2019 | 2.29% |
| Jun 30, 2019 | 1.43% |
| Jun 30, 2019 | 1.43% |
| Mar 31, 2019 | 3.67% |
| Mar 31, 2019 | 3.67% |
| Dec 31, 2018 | 32.06% |
| Dec 31, 2018 | 32.06% |